Roth MKM lowered the firm’s price target on Flora Growth (FLGC) to $4 from $5 but keeps a Buy rating on the shares after its Q3 results this week. The company continues to re-balance its assets and offerings, following the transitional year that shifted its focus away from Colombian cultivation and toward more profitable U.S./European branded opportunities, and while net sales declined y/y and q/q, adjusted EBITDA loss actually narrowed from Q2, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FLGC: